InVivo Therapeutics Holdings EBITDA 2010-2023 | NVIVQ

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

InVivo Therapeutics Holdings ebitda from 2010 to 2023. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

InVivo Therapeutics Holdings ebitda from 2010 to 2023. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.

Related Stocks
Company Name	Market Cap
Abbott Laboratories (ABT)	$218.9B
Boston Scientific (BSX)	$159.4B
Stryker (SYK)	$153B
EssilorLuxottica (ESLOY)	$136.1B
Medtronic (MDT)	$118B
Lonza Group Ag (LZAGY)	$50.9B
Haleon (HLN)	$43.8B
ResMed (RMD)	$40.1B
GE HealthCare Technologies (GEHC)	$35.4B
Agilent Technologies (A)	$33.9B
Terumo (TRUMY)	$25.3B
Koninklijke Philips (PHG)	$24.9B
Insulet (PODD)	$20.2B
Zimmer Biomet Holdings (ZBH)	$19.3B
Baxter (BAX)	$14.7B
Smith & Nephew SNATS (SNN)	$13.9B
Sunny Optical Technology (SNPTF)	$10.4B
Demant (WILYY)	$8.6B
Bio-Rad Laboratories (BIO)	$7B
Lantheus Holdings (LNTH)	$5.1B
Perrigo (PRGO)	$3.9B
Prestige Consumer Healthcare (PBH)	$3.8B
Haemonetics (HAE)	$3.6B
Envista Holdings (NVST)	$3.5B
Shandong Weigao Medical Polymer (SHWGF)	$3.5B
ICU Medical (ICUI)	$3.2B
LeMaitre Vascular (LMAT)	$1.9B
QuidelOrtho (QDEL)	$1.8B
AtriCure (ATRC)	$1.5B
Acuren (TIC)	$1.4B